Results 121 to 130 of about 5,245,219 (176)

Prevalence of migalastat-amenable variants in patients with Fabry disease from Brazil, Argentina, and Colombia: an observational study. [PDF]

Front Genet
Politei JM, Zarante Bahamón AM, Martins AM, Souza De Melo A, de Sa Pereira MH, Loures-Vale A, Veleva-Rotse BO, Krusinska E, Lengoc V.   +8 more
europepmc   +1 more source

VCAM-1 as a biomarker of early cardiac phenotypic changes in Fabry disease. [PDF]

BMC Cardiovasc Disord
Lino DODC, Meneses GC, de Almeida IM, Martins AMC, Vasconcelos AJS, de Lima CJM, Rocha RPS, Daher EF, da Silva Junior GB.   +8 more
europepmc   +1 more source

Cardiological aspects of Fabry disease: from diagnosis to therapeutic efficacy assessment. [PDF]

Orphanet J Rare Dis
Graziani F, Biagini E, Argirò A, Citro R, Iaccarino G, Lanzillo C, Monte I, Pieruzzi F, Zuchi C, Pieroni M.   +9 more
europepmc   +1 more source

Fabry Disease: Integrating Molecular Pathophysiology, Precision Diagnosis, and Artificial Intelligence Toward Precision Medicine. [PDF]

Cells
Biddeci G, Spinelli G, Colomba P, Anania M, Duro G, Di Blasi F.   +5 more
europepmc   +1 more source

Regarding: "Development and validation of a self-management efficacy questionnaire for patients with Fabry disease in China". [PDF]

Ann Med
Zhao D, Zhou W.
europepmc   +1 more source

Fabry Disease Diagnosed With Lung Nodule: A Unique Presentation in a Young Female Patient. [PDF]

Cureus
Joppich J, Mehta S, Mandavilli N, Rojas Alvarez F, Mehta V.   +4 more
europepmc   +1 more source

Multimodal phenotypic clustering predicts cardiac outcomes in Fabry disease. [PDF]

Orphanet J Rare Dis
Shemesh E, Feigin P, Tan CY, Rusk R, Gopalan D, Deegan P.   +5 more
europepmc   +1 more source

The impact of cardiovascular risk factors in non-classical Fabry disease. [PDF]

Orphanet J Rare Dis
Veldman BCF, van Dussen L, Datema MR, Meinsma R, Jansen-Meijer J, Koster J, van Kuilenburg ABP, Janssens M, Robbers LFHJ, Langeveld M.   +9 more
europepmc   +1 more source

Generation and characterization of induced pluripotent stem cells from a patient with classic Fabry disease. [PDF]

Intractable Rare Dis Res
Li G, Luan J, Li Z, Yang Y, Shao C, Wang J, Han Z, Wang Q, Zhu Y, Yu C, Cui Y, Han J.   +11 more
europepmc   +1 more source

Immuno-Inflammatory Profiling and Complement Activation in Fabry Disease: A Cross-Sectional Study. [PDF]

Int J Mol Sci
Peña-Rodríguez M, Bara-Ledesma N, Fabregate M, Morales Conejo M, Domínguez-Rodríguez F, Merino-Ortiz B, Stanescu S, Ruiz-Sala P, González García A, Belanger-Quintana A, López-Rodríguez M.   +10 more
europepmc   +1 more source